Ion-Selective Electrode Methods Compared for Electrolytes
|
By LabMedica International staff writers Posted on 02 Jul 2019 |
|
Image: The RAPIDPoint 500 Blood Gas System delivers fast, accurate and comprehensive test results for whole blood samples in approximately 60 seconds (Photo courtesy of Siemens Healthineers).
Electrolytes are among the most commonly requested clinical laboratory tests. There are two methods for measuring electrolytes in plasma, both using the principle of an ion-selective electrode (ISE).
The first method, used in point-of-care blood gas analyzers, is direct potentiometry, which measures electrolyte activity in plasma without dilution. The second method, used in routine chemistry analyzers in central laboratories, is indirect ISE, which involves a pre-analytical serum or plasma dilution step.
Clinical biochemists at the Leiden University Medical Center (Leiden, The Netherlands) and their colleagues used anonymized laboratory results of patients admitted to the emergency room and intensive care unit, and demonstrated in four steps that this lack of interchangeability of sodium and chloride results can be attributed to differences in measurement principle, but also to analytical standardization issues of the blood gas analyzers.
The team extracted blood gas results performed on a RAPIDPoint 500 and routine chemistry performed on a Modular P800 sodium and chloride results for patients admitted to the emergency room of their hospital between June 1, 2014, and May 17, 2016.
The team investigated the effects of the introduction of the instrument factors in the blood gas analysers, by extracting blood gas and routine chemistry sodium and chloride results (with a maximum time of 1 hour between sample analysis) again for patients admitted to the emergency room of our hospital. This approach eliminated the systematic differences between blood gas and serum sodium for 92 emergency department patients, and reduced the mean difference in chloride to 1 mmol/L for 25 patients. The mean difference in sodium results between blood gas and serum for intensive care patients decreased from 4 mmol/L to 2 mmol/L.
The authors concluded that standardization of sodium and chloride across methods and matrices is not a simple task and emphasizes the need for a close collaboration between laboratory specialists and clinicians regarding education on pitfalls in laboratory medicine. The study was published on June 13, 2019, in the journal Practical Laboratory Medicine.
Related Links:
Leiden University Medical Center
The first method, used in point-of-care blood gas analyzers, is direct potentiometry, which measures electrolyte activity in plasma without dilution. The second method, used in routine chemistry analyzers in central laboratories, is indirect ISE, which involves a pre-analytical serum or plasma dilution step.
Clinical biochemists at the Leiden University Medical Center (Leiden, The Netherlands) and their colleagues used anonymized laboratory results of patients admitted to the emergency room and intensive care unit, and demonstrated in four steps that this lack of interchangeability of sodium and chloride results can be attributed to differences in measurement principle, but also to analytical standardization issues of the blood gas analyzers.
The team extracted blood gas results performed on a RAPIDPoint 500 and routine chemistry performed on a Modular P800 sodium and chloride results for patients admitted to the emergency room of their hospital between June 1, 2014, and May 17, 2016.
The team investigated the effects of the introduction of the instrument factors in the blood gas analysers, by extracting blood gas and routine chemistry sodium and chloride results (with a maximum time of 1 hour between sample analysis) again for patients admitted to the emergency room of our hospital. This approach eliminated the systematic differences between blood gas and serum sodium for 92 emergency department patients, and reduced the mean difference in chloride to 1 mmol/L for 25 patients. The mean difference in sodium results between blood gas and serum for intensive care patients decreased from 4 mmol/L to 2 mmol/L.
The authors concluded that standardization of sodium and chloride across methods and matrices is not a simple task and emphasizes the need for a close collaboration between laboratory specialists and clinicians regarding education on pitfalls in laboratory medicine. The study was published on June 13, 2019, in the journal Practical Laboratory Medicine.
Related Links:
Leiden University Medical Center
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
Urine Chemistry Control
Dropper Urine Chemistry Control
New
Gold Member
Automatic CLIA Analyzer
Shine i9000
Latest Technology News
- Artificial Intelligence Model Could Accelerate Rare Disease Diagnosis
- AI Saliva Sensor Enables Early Detection of Head and Neck Cancer
- AI-Powered Biosensor Technology to Enable Breath Test for Lung Cancer Detection
- AI Model Achieves Breakthrough Accuracy in Ovarian Cancer Detection
- Portable Biosensor Diagnoses Psychiatric Disorders Using Saliva Samples
- Cell-Sorting Device Uses Electromagnetic Levitation to Precisely Direct Cell Movement
- Embedded GPU Platform Enables Rapid Blood Profiling for POC Diagnostics
- Viral Biosensor Test Simultaneously Detects Hepatitis and HIV
- Acoustofluidic Device to Transform Point-Of-Care sEV-Based Diagnostics
- AI Algorithm Assesses Progressive Decline in Kidney Function
Channels
Molecular Diagnostics
view channel
Simple Urine Test to Revolutionize Bladder Cancer Diagnosis and Treatment
Bladder cancer is one of the most common and deadly urological cancers and is marked by a high rate of recurrence. Diagnosis and follow-up still rely heavily on invasive cystoscopy or urine cytology, which... Read more
Blood Test to Enable Earlier and Simpler Detection of Liver Fibrosis
Persistent liver damage caused by alcohol misuse or viral infections can trigger liver fibrosis, a condition in which healthy tissue is gradually replaced by collagen fibers. Even after successful treatment... Read more
Hematology
view channel
Platelet Activity Blood Test in Middle Age Could Identify Early Alzheimer’s Risk
Early detection of Alzheimer’s disease remains one of the biggest unmet needs in neurology, particularly because the biological changes underlying the disorder begin decades before memory symptoms appear.... Read more
Microvesicles Measurement Could Detect Vascular Injury in Sickle Cell Disease Patients
Assessing disease severity in sickle cell disease (SCD) remains challenging, especially when trying to predict hemolysis, vascular injury, and risk of complications such as vaso-occlusive crises.... Read more
ADLM’s New Coagulation Testing Guidance to Improve Care for Patients on Blood Thinners
Direct oral anticoagulants (DOACs) are one of the most common types of blood thinners. Patients take them to prevent a host of complications that could arise from blood clotting, including stroke, deep... Read more
Immunology
view channel
New Test Distinguishes Vaccine-Induced False Positives from Active HIV Infection
Since HIV was identified in 1983, more than 91 million people have contracted the virus, and over 44 million have died from related causes. Today, nearly 40 million individuals worldwide live with HIV-1,... Read more
Gene Signature Test Predicts Response to Key Breast Cancer Treatment
DK4/6 inhibitors paired with hormone therapy have become a cornerstone treatment for advanced HR+/HER2– breast cancer, slowing tumor growth by blocking key proteins that drive cell division.... Read more
Chip Captures Cancer Cells from Blood to Help Select Right Breast Cancer Treatment
Ductal carcinoma in situ (DCIS) accounts for about a quarter of all breast cancer cases and generally carries a good prognosis. This non-invasive form of the disease may or may not become life-threatening.... Read more
Microbiology
view channel
Rapid Diagnostic Test Matches Gold Standard for Sepsis Detection
Sepsis kills 11 million people worldwide every year and generates massive healthcare costs. In the USA and Europe alone, sepsis accounts for USD 100 billion in annual hospitalization expenses.... Read more
Rapid POC Tuberculosis Test Provides Results Within 15 Minutes
Tuberculosis remains one of the world’s deadliest infectious diseases, and reducing new cases depends on identifying individuals with latent infection before it progresses. Current diagnostic tools often... Read more
Rapid Assay Identifies Bloodstream Infection Pathogens Directly from Patient Samples
Bloodstream infections in sepsis progress quickly and demand rapid, precise diagnosis. Current blood-culture methods often take one to five days to identify the pathogen, leaving clinicians to treat blindly... Read more
Pathology
view channel
Tunable Cell-Sorting Device Holds Potential for Multiple Biomedical Applications
Isolating rare cancer cells from blood is essential for diagnosing metastasis and guiding treatment decisions, but remains technically challenging. Many existing techniques struggle to balance accuracy,... Read more
AI Tool Outperforms Doctors in Spotting Blood Cell Abnormalities
Diagnosing blood disorders depends on recognizing subtle abnormalities in cell size, shape, and structure, yet this process is slow, subjective, and requires years of expert training. Even specialists... Read more
Technology
view channel
Artificial Intelligence Model Could Accelerate Rare Disease Diagnosis
Identifying which genetic variants actually cause disease remains one of the biggest challenges in genomic medicine. Each person carries tens of thousands of DNA changes, yet only a few meaningfully alter... Read more
AI Saliva Sensor Enables Early Detection of Head and Neck Cancer
Early detection of head and neck cancer remains difficult because the disease produces few or no symptoms in its earliest stages, and lesions often lie deep within the head or neck, where biopsy or endoscopy... Read more
Industry
view channel
Abbott Acquires Cancer-Screening Company Exact Sciences
Abbott (Abbott Park, IL, USA) has entered into a definitive agreement to acquire Exact Sciences (Madison, WI, USA), enabling it to enter and lead in fast-growing cancer diagnostics segments.... Read more
